Loading clinical trials...
Loading clinical trials...
To value the accuracy of the dosing algorithm published by the International Warfarin Pharmacogenetics Consortium in Chinese patients after heart valve replacement. To value the accuracy of warfarin ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Guangdong Provincial People's Hospital
NCT05208567 · Heart Valve Diseases, Left Ventricular Dysfunction
NCT07390903 · Cardiopulmonary Bypass, Coronary Artery Bypass, and more
NCT07267117 · Heart Valve Disease, Mitral Valve (MV) Regurgitation, and more
NCT03142152 · Functional Mitral Regurgitation, Heart Failure, and more
NCT06467513 · Heart Diseases, Heart Valve Diseases
Guangdong General Hospital
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions